Alamar Biosciences (NASDAQ:ALMR) Major Shareholder Innovation Fund Gp Illumina II Purchases 235,294 Shares

Alamar Biosciences, Inc. (NASDAQ:ALMR) major shareholder Innovation Fund Gp Illumina II acquired 235,294 shares of the company’s stock in a transaction dated Monday, April 20th. The shares were bought at an average price of $17.00 per share, for a total transaction of $3,999,998.00. Following the acquisition, the insider directly owned 507,076 shares of the company’s stock, valued at approximately $8,620,292. This trade represents a 86.57% increase in their position. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. Major shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.

Alamar Biosciences Price Performance

ALMR stock opened at $22.00 on Tuesday. Alamar Biosciences, Inc. has a 1 year low of $21.50 and a 1 year high of $24.50.